Helios supports Phase II-IV clinical trials across various therapeutic areas. Our expedited startup process means our high-quality recruitment begins quickly, and our rigorous screening and reputation for exceeding expectations means studies meet or exceed enrollment and randomization goals with high completion rates and minimal screening failures.
0
+
research trials across multiple therapeutic areas
0
+
patients supported through the clinical trial journey
1
single contract/budget provides access to all Helios sites
Our team’s experience includes:
- Allergy/Immunology
- OB/GYN
- Dermatology
- Family Medicine
- Gastroenterology
- Internal Medicine
- Maternal Vaccines
- Metabolic
- Orthopedics
- Pediatrics
- Rheumatology
- Urgent Care
- Vaccines
- Urology
- Oncology
Example of our work:
Delivering diverse enrollment for maternal vaccine study
Respiratory illnesses like RSV can be especially risky for young infants, but an RSV vaccine given during the third trimester of pregnancy potentially could protect babies after they are born. Our team drove randomization of 501 patients at eight sites in just 19 weeks for the sponsor of an RSV vaccine study. We did it by engaging our community OBGYN referral network and leveraging connections among trusted physicians to increase interest. Our sites were ranked in the top 10 of all sites participating in the study and enrollment by our team helped double study diversity.
